07Sep 2022
Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study

Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study

This study determined the prevalence of cancer as a comorbid in COVID-19 patients, severe events, case fatality rate, history of anticancer therapy associated with extreme circumstances, and type of cancer in cancer patients with COVID-19 in the world. The prevalence of cancer as a comorbid in COVID-19 patients was 4.63% worldwide. The high prevalence of cancer as a comorbid among COVID-19 patients indicates the susceptibility of cancer patients to SARS-CoV-2 infection. Furthermore, cancer is comorbid in COVID-19 patients, and anticancer therapy increases severe events of COVID-19.

  • #family health

Like

Save

Share